The future of drug discovery: Using AI to optimise the hit-to-lead process
Drug Discovery World
AUGUST 20, 2024
It’s therefore no surprise that pharmaceutical companies are increasingly interested in using artificial intelligence (AI) to accelerate development and reduce costs. Research shows that companies could shorten this cycle by up to 30 months 2 over the course of the small molecule drug discovery process by applying AI.
Let's personalize your content